At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 40 enrolled
Drug / intervention
ARC-520 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ARC-520 at Varying Infusion Rates in Normal Adult Volunteers
In Brief
A Phase 1 clinical trial evaluating ARC-520, cetirizine, and 1 other intervention for Healthy. Completed, enrolled 40 participants across 1 site.
Detailed Summary
Single doses of ARC-520 will be evaluated at varying infusion rates and by slow bolus push.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesAustralia
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 2015
Enrollment StartSep 2015
Primary CompletionAug 2016
TodayJul 2026
First PostedAug 28, 2015
Enrollment StartSep 1, 2015
Primary CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.8 years ago
Interventions
ARC-520drug
cetirizinedrug
diphenhydraminedrug